respiratory
COPD

Alarming findings show need to prioritise COPD patients for COVID-19 vax

COPD is a significant risk factor for adverse outcomes from COVID-19 – justifying its inclusion as criteria for the phase 1b priority list for COVID-19 vaccination, an Australian respiratory physician says. A recent systematic review of the evidence has shown that COPD patients who contract COVID-19 are four times more likely to be hospitalised, 1.3 ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic